000 | 02077nam a22003137a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20240305192332.0 | ||
008 | 220216b |||||||| |||| 00| 0 eng d | ||
020 | _a140206845X | ||
020 | _a9781402068454 | ||
040 | _cData centre | ||
100 |
_aFranco Cataldo _931305 |
||
245 | _aMedicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes | ||
250 | _a illustrated | ||
260 |
_aRome _bSpringer Science & Business Media _c 2008 |
||
300 | _a408 pages | ||
490 | _vVolume 1 of Carbon Materials: Chemistry and Physics | ||
520 | _aFullerenes and nanotubes are two classes of carbon structures or allotropes, which were discovered about 17 years ago. Since that time, many chemical derivatives have been synthesized using fullerenes and nanotubes as building blocks. Particularly promising was the theory that the chemical properties of fullerenes, and certain derivatives, made them likely candidates for anticancer drugs, inhibitors of viruses such as HIV, or even as anti-bacterials. Their cyctotoxicity can also be controlled by specific circumstances. In addition, the funtionalization of nanotubes has not only produced relatively simple derivatives, but also complex hybrids with biological macromolecules, which show unique supramolecular architecture and which are promising in many medical applications. The application of fullerenes and nanotubes in medicine is at the frontier of our knowledge, thus the work in this field represents the basis for future novel developments. | ||
600 |
_xTechnology & Engineering / Nanotechnology & MEMS _928423 |
||
600 |
_xTechnology & Engineering / Materials Science / General _931306 |
||
600 |
_x Science / Life Sciences / Biochemistry _927147 |
||
600 |
_xScience / Chemistry / Clinical _927637 |
||
600 |
_xMedical / Pharmacology _927230 |
||
600 |
_x Medical / Oncology / General _926891 |
||
600 |
_x Medical / General _926821 |
||
600 |
_x Science › Chemistry › Clinical _928647 |
||
700 |
_aTatiana da Ros _931307 |
||
942 |
_2ddc _cEB |
||
999 |
_c4988 _d4988 |